Taiwan FDA registration ef07edbda7d87e9507aee17f147cc2e6
"Kaijie" fast Yapa automatic nucleic acid purification system (unsterilized)
TW: "凱杰"快亞柏全自動核酸純化系統 (未滅菌)
Taiwan·Risk Class 1·QIAGEN GMBH·Registered May 27, 2022 – May 27, 2027ActiveRegistration details
- Analysis ID
- ef07edbda7d87e9507aee17f147cc2e6
- Customs Code
- DHA09402281501
Company information
- Manufacturer
- QIAGEN GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- QIAGEN TAIWAN COMPANY LIMITED
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, the first level identification range of the "ribonucleonic acid analysis pretreatment system (C.4070)".
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.4070 核醣核酸分析前處理系統
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- May 27, 2022
- Expiry Date
- May 27, 2027
About this record
Access comprehensive regulatory information for "Kaijie" fast Yapa automatic nucleic acid purification system (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number ef07edbda7d87e9507aee17f147cc2e6 and manufactured by QIAGEN GMBH. The authorized representative in Taiwan is QIAGEN TAIWAN COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices